[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341062-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-341062-en":123},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","targeting-cancer-hallmarks-with-epigallocatechin-gallate-egcg-mechanistic-basis-and-therapeutic-targets","Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG) - Mechanistic Basis and Therapeutic Targets","","Epigallocatechin gallate (EGCG) is a green-tea catechin studied for anticancer potential, showing anti-proliferative, anti-angiogenic, and pro-apoptotic effects across cancer cell lines and animal models. The review highlights how EGCG disrupts multiple signaling pathways driving cellular proliferation, division, and tumor progression. It links these activities to interference with recognized cancer hallmarks, emphasizing EGCG’s mechanistic versatility as a therapeutic tool. The discussion supports further scientific and clinical investigation into EGCG as a potential anticancer treatment.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-cancer-hallmarks-with-epigallocatechin-gallate-egcg-mechanistic-basis-and-therapeutic-targets/341062/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-cancer-hallmarks-with-epigallocatechin-gallate-egcg-mechanistic-basis-and-therapeutic-targets/341062.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of the review?","Question",{"text":63,"@type":64},"The review aims to highlight EGCG as a promising natural compound for cancer prevention and treatment. It focuses on how EGCG impacts cancer hallmarks and encourages further scientific and clinical investigation.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},341062,1790818894,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,103,107,112,115,119],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":99,"doc_module":4,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},7,"Healthcare",40,"healthcare",{"id":104,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":105,"slug":106},8,30,"research-report",{"id":108,"doc_module":4,"doc_module_name":25,"category_name":109,"show_sort_weight":110,"slug":111},9,"Religion & Spirituality",20,"religion-spirituality",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":113,"show_sort_weight":110,"slug":114},"World Cup","world-cup",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":116,"slug":118},10,"Lifestyle","lifestyle",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":89,"slug":122},19,"General","general",{"code":4,"msg":74,"data":124},{"doc_id":71,"user_id":125,"nickname":42,"user_avatar":126,"doc_module":4,"category_id":104,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":127,"file_id":128,"file_url":129,"file_type":130,"file_size":131,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":132,"language":133,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":134,"faqs":135,"seo_title":136,"seo_description":12,"update_tm":137,"read_time":138,"preview_page_count":33,"preview_urls":139},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","molecules   \nReview  \nTargeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets  \nWamidh H. Talib 1, *, Dima Awajan 2, Abdelrahim Alqudah 3, Razan Alsawwaf 2, Raha Althunibat 2, Mahmoud Abu AlRoos 2, Ala’a Al Safadi 2, Sharif Abu Asab 2, Rawan W. Hadi 1 and Lina T. Al Kury 4, *  \nCitation: Talib, W.H.; Awajan, D.; Alqudah, A.; Alsawwaf, R.;  \nAlthunibat, R.; Abu AlRoos, M.; Al Safadi, A.; Abu Asab, S.; Hadi, R.W.; Al Kury, L.T. Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets. Molecules 2024, 29, 1373. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/molecules29061373](10.3390/molecules29061373)  \nAcademic Editors: Agnieszka Szewczyk and Inga Kwiecien  \nReceived: 31 January 2024  \nRevised: 2 March 2024  \nAccepted: 8 March 2024  \nPublished: 20 March 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Faculty of Allied Medical Sciences, Applied Science Private University, Amman 11931, Jordan; [rawanalyasari2001@gmail.com](rawanalyasari2001@gmail.com)  \n2 Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman 11931, Jordan; [dimaawajan@gmail.com](dimaawajan@gmail.com) (D.A.); [razan.sawwaf@gmail.com](razan.sawwaf@gmail.com) (R.A.); [rahaalthunibat@gmail.com](rahaalthunibat@gmail.com) (R.A.); [mahmoudabualroos@gmail.com](mahmoudabualroos@gmail.com) (M.A.A.); [alaa.safadi9@gmail.com](alaa.safadi9@gmail.com) (A.A.S.);  \n[shareef.ashour@gmail.com](shareef.ashour@gmail.com) (S.A.A.)  \n3 Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan; [abdelrahim@hu.edu.jo](abdelrahim@hu.edu.jo)  \n4 Department of Health Sciences, College of Natural and Health Sciences, Zayed University, Abu Dhabi 144534, United Arab Emirates  \n* [Correspondence: w_talib@asu.edu.jo](Correspondence: w_talib@asu.edu.jo) (W.H.T.); [lina.alkury@zu.ac.ae](lina.alkury@zu.ac.ae) (L.T.A.K.)  \nAbstract: Epigallocatechin gallate (EGCG) is a catechin, which is a type of flavonoid found in high concentrations in green tea. EGCG has been studied extensively for its potential health benefits, particularly in cancer. EGCG has been found to exhibit anti-proliferative, anti-angiogenic, and proapoptotic effects in numerous cancer cell lines and animal models. EGCG has demonstrated the ability to interrupt various signaling pathways associated with cellular proliferation and division in different cancer types. EGCG anticancer activity is mediated by interfering with various cancer hallmarks. This article summarize and highlight the effects of EGCG on cancer hallmarks and focused on the impacts of EGCG on these cancer-related hallmarks. The studies discussed in this review enrich the understanding of EGCG’s potential as a therapeutic tool against cancer, offering a substantial foundation for scientists and medical experts to advance scientific and clinical investigations regarding EGCG’s possibility as a potential anticancer treatment.  \nKeywords: epigallocatechin gallate (EGCG); cancer hallmarks; anticancer; angiogenesis; metastasis; immune evasion  \n1. Introduction  \nCancer continues to be a leading cause of mortality worldwide, presenting a significant challenge to public health [1] . Over the years, extensive research efforts have been implemented to explore various therapeutic strategies aimed at combating cancer. Among the evolving prospects in cancer treatments, there has been a noteworthy focus on natural compounds originating from plants. This focus is credited to their potential as anticancer agents [2] . One of these comp","cbCaieEl7pltEbJi","https://ap.wps.com/l/cbCaieEl7pltEbJi","pdf",2322931,25,"English","# 1. Introduction\n## 1.1. Pharmacokinetic Properties of EGCG","[{\"question\":\"What is the purpose of the review?\",\"answer\":\"The review aims to highlight EGCG as a promising natural compound for cancer prevention and treatment. It focuses on how EGCG impacts cancer hallmarks and encourages further scientific and clinical investigation.\"}]","Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG) - Mechanistic Basis and Therapeutic Targets | PDF",1790040122,63,[140,144,148,152],{"page_no":22,"url":141,"width":142,"height":143},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/daa1a59eb255b610c987a8a9c826f19d.webp",983,1390,{"page_no":26,"url":145,"width":146,"height":147},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/061a859355261095dec0149967f98c38.webp",982,1388,{"page_no":30,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fba0bb157eb5138f9f7820d377849c4c.webp",981,1387,{"page_no":33,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/294e0bf215e43854d9093300f7722c65.webp",980,1385]